To evaluate the value of ultrasound and clinical risk factors in predicting severe hemorrhage (>1.5 l) in pregnancies undergoing Caesarean section for placenta previa/accreta. Methods: A retrospective review of all cases of placenta previa/accreta undergoing Caesarean delivery over a period of 5 years in a regional service unit. Cases were identified and delivery data was retrieved from a comprehensive obstetric database. Detailed ultrasound findings from the examination just before delivery were obtained from manual review of individual records. Results: There were a total of 21908 deliveries within the review period of 2012 to 2016, and the incidence of Caesarean section for placenta previa/accreta was 0.98% (n=215). Of these, 12.1% (n=26) had severe postpartum hemorrhage (PPH) with blood loss of 1.5 l. There were 6 cases of placenta accreta (2.8%), of which one had classical Caesarean section with the placenta left in situ and another had classical section and direct hysterectomy, so that both of them did not have severe PPH. Univariate analysis showed that advanced maternal age, previous pregnancies with previa or PPH, the type of previa or distance of the placental edge from the os, occurrence of antepartum hemorrhage before delivery, anterior placenta, thick placental edge and presence of accreta were all significantly associated with severe PPH. A logistic regression model showed that major previa, APH before delivery and anterior placenta remained significant factors associated with severe PPH, whereas other factors were excluded. Due to the differential treatment for accreta cases, placenta accreta was not a significant factor in the final equation. The sensitivity/specificity and positive/negative predictive value of the model for severe hemorrhage are 61.5%, 96.8%, 72.7% and 94.5% respectively. Conclusions: The significant ultrasound and clinical factors identified as predictive factors for severe PPH could be used as a model for triaging risks when planning Caesarean section delivery for placenta previa/accreta.
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Predictive factors for retained products of conception after miscarriage or termination in the second trimester: a retrospective case-controlled study Objectives: Retained products of conception (RPOC) is one of the complications after miscarriage or termination in the second trimester. RPOC is the cause of abnormal bleeding, which occasionally leads to maternal crisis. As the risk factors for RPOC after second trimester miscarriage or termination are not well-known, we conducted a retrospective study to evaluate the risk factors for RPOC.
Methods:
In this retrospective case-controlled study, we enrolled 98 women who had miscarriage or termination from 12 weeks and 0 days to 21 weeks and 6 days (in Japan, period of abortion was defined as fewer than 22 weeks), between January 2011 and September 2017 at our hospital. RPOC in the uterus was diagnosed by transvaginal ultrasonography as a solid mass lesion with or without hyper-vascularity using colour Doppler. Our study was approved by the Institutional Review Board. Results: Of the enrolled 98 women, 18 were positive for RPOC and 80 women were negative. The timing of delivery for RPOC positive was earlier than for RPOC negative (16.8 weeks [12.1-20.4 
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Objectives: The three subtypes of placenta accreta are placenta accreta vera where villi are attachment to the myometrium, placenta increta where villi invade the myometrium deeply and placenta percreta where villi penetrates the entire thickness of myometrium, including perforation through the uterine serosa. The ultrasound features of abnormal placentation has been documented, but evaluation still poses many challenges. Our department has been performing evaluation of placenta accreta since 2003 and results concurred with operative findings. Methods: 62 cases of placenta accreta and 30 cases of controls were included in this review. There were 35 cases of placenta accreta vera, 18 cases of placenta increta and 9 cases of placenta percreta. Transabdominal and transvaginal techniques with colour and power Doppler were utilised. Results: Gray-scale findings in abnormal placentation included: (i) absence of retroplacental hypoechoic space; (ii) presence of placental lacunae with flow; (iii) abnormal subplacental vasculature with high velocity and low-impedance flow; (iv) presence of abnormal flow in adjacent organs e.g. bladder may be observed. Conclusions: Important points of note included: (i) placenta percreta (the above-mentioned features were all very remarkable); (ii) placenta increta and accreta vera (in some cases not all features are present); (iii) we found that gynecological settings in colour Doppler would be able to show the placental lacunae flow; (iii) cases with segmented adherence would require meticulous thorough evaluation to identify these abnormalities. We have cases where the CT or MRI were unable to identify the problematic regions. (iv) In the controls there are 2 cases which the retroplacental appeared almost absent. Meticulous evaluation revealed leaving only a thin
